SBRCY
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 James B. RenacciHouse · R · OH |
SBRCYSBRCY · Stock |
Sale $15,001 - $50,000 |
Apr 8, 2014 | Mar 25, 2014 | Filing ↗ |
Whale Activity
No 13F positions in SBRCY among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
No insider transactions on record.
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Emerging Markets Equity Fund John Hancock Investment Trust | 558.4K | $2.5M | 0.17% | Jul 31, 2026 |
| Brown Advisory Emerging Markets Select Fund Brown Advisory Funds | 184.8K | $827K | 0.08% | Jun 30, 2026 |
| Pzena Emerging Markets Value Fund Advisors Series Trust | 408.5K | $4K | 0.00% | May 31, 2026 |
| Fidelity Series Emerging Markets Opportunities Fund Fidelity Investment Trust | 19.6M | $196 | 0.00% | Apr 30, 2026 |
| Fidelity Advisor Focused Emerging Markets Fund Fidelity Advisor Series VIII | 3.2M | $32 | 0.00% | Apr 30, 2026 |
| VIP Emerging Markets Portfolio VARIABLE INSURANCE PRODUCTS FUND II | 1.8M | $18 | 0.00% | Mar 31, 2026 |
| Strategic Advisers Fidelity Emerging Markets Fund Fidelity Rutland Square Trust II | 1.7M | $17 | 0.00% | May 31, 2026 |
| Fidelity Emerging Markets Equity Central Fund Fidelity Central Investment Portfolios LLC | 1.5M | $15 | 0.00% | Mar 31, 2026 |
| Strategic Advisers Emerging Markets Fund Fidelity Rutland Square Trust II | 1.3M | $13 | 0.00% | May 31, 2026 |
| AST J.P. Morgan Moderate Multi-Asset Portfolio ADVANCED SERIES TRUST | 18.6K | $2 | 0.00% | Mar 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list SBRCY's shares (CUSIP 80585Y308), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming SBRCY as the client.
Government Contracts
No federal contract awards found for SBRCY.
U.S. Patents
No USPTO patent applications found for SBRCY.
Annual Financials
No annual XBRL figures on record for SBRCY. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
No price history on record for SBRCY.
Material Events (8-K)
No 8-K filings on record.
About SBRCY
No company profile on record.